MAM
PCRX icon

Milestone Asset Management’s Pacira BioSciences PCRX Stock Holding History

Milestone Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Sell
51,957
-8,101
-13% -$191K 0.21% 110
2026
Q1 		$1.36M Buy
60,058
+8,953
+18% +$199K 0.25% 95
2025
Q4 		$1.32M Buy
+51,105
New +$1.22M 0.25% 79

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Milestone Asset Management's PCRX Position: Q2 2026 in Review

Milestone Asset Management reduced its Pacira BioSciences (PCRX) stake by 13% in Q2 2026, selling an estimated $191K and leaving 51,957 shares worth $1.32M. The position accounts for 0.21% of the portfolio, ranked #110.

Milestone Asset Management first reported a position in PCRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.36M in Q1 2026. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Milestone Asset Management held 51,957 shares of Pacira BioSciences worth $1.32M as of Q2 2026.
  • Milestone Asset Management sold 8,101 Pacira BioSciences shares in Q2 2026, an estimated $191K.
  • Pacira BioSciences made up 0.21% of Milestone Asset Management's portfolio in Q2 2026, its #110 holding.
  • Milestone Asset Management first reported a position in Pacira BioSciences in Q4 2025 and has held it in 3 quarters since.
  • Milestone Asset Management's Pacira BioSciences position peaked at $1.36M in Q1 2026.
  • 253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Milestone Asset Management's 13F filing for Q2 2026, filed 15 Jul 2026.